Your institution may have access to this item. Find your institution then sign in to continue.
Title
Mixed results for a malaria vaccine.
Abstract
The article presents comments of three experts on implications of ongoing phase 3 trial to assess the candidate malaria vaccine RTS,S/AS01. Michael F. Good says that the trial indicates that vaccinated individuals are afforded significant protection in the first few months after vaccination. Adrian V. S. Hill says that the trial presents the possibility of a vaccine that could control mortality and morbidity caused by malaria.